5paisa Capital Limited Receives SEBI Research Analyst Registration Certificate

1 min read     Updated on 27 Feb 2026, 11:00 AM
scanx
Reviewed by
Suketu GScanX News Team
Overview

5paisa Capital Limited has received SEBI Research Analyst registration certificate under SEBI (Research Analysts) Regulations, 2014. The approval was communicated on February 26, 2026, enabling the company to undertake research analyst activities. The certificate is valid for five years and is expected to support the company's business operations within the regulatory framework.

33715804

*this image is generated using AI for illustrative purposes only.

5paisa capital Limited has announced that it has received a Certificate of Registration as a Research Analyst from the Securities and Exchange Board of India (SEBI). The approval was communicated through SEBI's email dated February 26, 2026, with the company making the disclosure on February 27, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Registration Details

The registration certificate has been granted under the SEBI (Research Analysts) Regulations, 2014, which will enable the company to undertake and carry on activities as a Research Analyst in accordance with applicable regulations.

Parameter Details
Regulatory Authority Securities and Exchange Board of India (SEBI)
Registration Type Research Analyst Certificate
Approval Date February 26, 2026
Disclosure Date February 27, 2026
Validity Period Five years from grant date

Business Impact

According to the company's disclosure, this registration is expected to support 5paisa Capital's business activities by allowing it to conduct research analyst operations. The certificate enables the company to expand its service offerings within the regulatory framework established by SEBI for research analysts.

Regulatory Compliance

The certificate is valid for a period of five years from the date of grant of registration, subject to payment of applicable renewal fees as prescribed under the SEBI (Research Analysts) Regulations, 2014. The company has made this disclosure in compliance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Key Features

  • Registration allows research analyst activities under SEBI regulations
  • Five-year validity period with renewal option
  • Expected to enhance the company's business capabilities
  • Full compliance with SEBI disclosure requirements

The disclosure was signed by Charvi Panchmatia, Company Secretary & Compliance Officer, and submitted to both BSE Limited and the National Stock Exchange of India Limited as required under the listing regulations.

Historical Stock Returns for 5Paisa Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+0.44%+2.79%-4.45%-9.97%-9.12%+23.45%

5paisa Capital Schedules February 28 Board Meeting for Rights Issue Terms

2 min read     Updated on 24 Feb 2026, 08:12 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

5paisa Capital Limited's board approved a ₹4,750.00 million rights issue on February 24, 2026, and has now scheduled another meeting for February 28, 2026, to determine crucial terms including issue price, rights entitlement ratio, and record date. The rights issue involves fully paid equity shares with ₹10 face value for eligible shareholders, subject to regulatory approvals under SEBI regulations.

33489725

*this image is generated using AI for illustrative purposes only.

5paisa capital Limited's Board of Directors has approved a significant rights issue to raise funds up to ₹4,750.00 million, marking a major capital raising initiative for the financial services company. The board meeting held on February 24, 2026, considered and approved the issuance of fully paid equity shares with a face value of ₹10 each through a rights offering to eligible shareholders.

Rights Issue Details

The rights issue will be offered to eligible equity shareholders of the company as on the record date, which will be determined and notified at a later stage. The fundraising initiative is designed to comply with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Parameter: Details
Issue Type: Rights Issue
Securities Type: Fully paid-up equity shares
Face Value: ₹10 per share
Maximum Amount: ₹4,750.00 million
Eligible Investors: Equity shareholders as on record date

Upcoming Board Meeting for Terms Finalization

Following the initial approval, the company has scheduled another board meeting for February 28, 2026, to determine the specific terms of the rights issue. This meeting will address crucial aspects that were delegated to the Rights Issue Committee during the February 24 board meeting.

Meeting Details: Information
Meeting Date: February 28, 2026
Meeting Day: Saturday
Purpose: Finalize rights issue terms
Regulatory Compliance: Regulation 29 of SEBI Listing Regulations

Key Terms to be Determined

The upcoming board meeting will focus on finalizing several critical parameters of the rights issue that will directly impact shareholders and the offering's success.

The specific terms that will be decided include:

  • Issue price determination
  • Rights entitlement ratio
  • Record date fixation
  • Timing of the rights issue
  • Terms of payment
  • Other matters incidental to the offering

Regulatory Compliance and Documentation

The rights issue proposal is subject to receipt of regulatory approvals as required under applicable laws. The company has disclosed the requisite details in compliance with Regulation 30 read with Schedule III of the SEBI Listing Regulations. The latest intimation about the February 28 board meeting has been made under Regulation 29 of the SEBI Listing Regulations.

Regulatory Aspect: Details
Compliance Framework: SEBI ICDR Regulations 2018
Meeting Intimation: Regulation 29 SEBI Listing Regulations
Outcome Disclosure: Regulation 30 with Schedule III
Company Secretary: Charvi Panchmatia (ICSI: A49189)

Communication and Timeline

The board meeting of February 24, 2026, commenced at 06:30 PM IST and concluded at 07:30 PM IST. The company had previously intimated about this meeting on February 19, 2026, in accordance with regulatory requirements. The meeting outcome and the subsequent intimation about the February 28 meeting have been formally communicated to both BSE Limited and the National Stock Exchange of India Limited, with the information also uploaded on the company's website at www.5paisa.com .

Historical Stock Returns for 5Paisa Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+0.44%+2.79%-4.45%-9.97%-9.12%+23.45%

More News on 5Paisa Capital

1 Year Returns:-9.12%